Laura Davis
Family Medicine · Blountstown, FLNPI 1982042735
Payments from drug & device makers
Across 327 payments — averaging $17.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$922
- Boehringer Ingelheim$748
- Lilly USA, LLC$714
- Novo Nordisk$459
- Amgen$337
- Dexcom, Inc.$331
- plus $2K from 30 others
What the payments were for
- Food & beverage$5,840100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 47 | $922 |
| Boehringer Ingelheim | 29 | $748 |
| Lilly USA, LLC | 54 | $714 |
| Novo Nordisk | 30 | $459 |
| Amgen | 21 | $337 |
| Dexcom, Inc. | 11 | $331 |
| Johnson & Johnson | 22 | $318 |
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $281 |
| Merck | 16 | $259 |
| GSK | 12 | $195 |
| AbbVie | 5 | $180 |
| Novartis | 8 | $145 |
| Pfizer | 8 | $140 |
| Kowa Pharmaceuticals America, Inc. | 8 | $119 |
| Boston Scientific | 3 | $73 |
| Exact Sciences | 4 | $71 |
| Sanofi-aventis U.S. LLC | 4 | $64 |
| Amarin Pharma, Inc. | 4 | $56 |
| Philips North America LLC | 3 | $52 |
| Melinta Therapeutics, LLC | 2 | $43 |
| Xeris Pharmaceuticals, Inc. | 2 | $41 |
| Astellas Pharma US Inc | 2 | $35 |
| Jazz Pharmaceuticals Inc. | 2 | $32 |
| Servier Pharmaceuticals LLC | 1 | $30 |
| Shire North American Group Inc | 2 | $29 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $24 |
| Global Blood Therapeutics, Inc. | 1 | $18 |
| Sunovion Pharmaceuticals Inc. | 1 | $17 |
| Nestle Healthcare Nutrition Inc. | 1 | $16 |
| Bayer | 1 | $16 |
| Ironshore Pharmaceuticals Inc. | 1 | $15 |
| Phathom Pharmaceuticals, Inc. | 1 | $14 |
| Vivus LLC | 1 | $14 |
| Sanofi Pasteur Inc. | 1 | $14 |
| Corium, LLC | 1 | $12 |
| Avanir Pharmaceuticals, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,846 in reported general payments places this provider in the 85th percentile of 7,282 family medicine providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 84 | $129,012 |
| FarxigaDapagliflozin Propanediol | 129 | $124,561 |
| EliquisApixaban | 165 | $118,566 |
| MounjaroTirzepatide | 79 | $100,682 |
| JardianceEmpagliflozin | 75 | $63,681 |
| JanuviaSitagliptin Phosphate | 48 | $40,449 |
| Tresiba Flextouch U-200Insulin Degludec | 14 | $34,518 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 39 | $31,441 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 32 | $29,769 |
| TrulicityDulaglutide | 30 | $29,513 |
| XareltoRivaroxaban | 41 | $26,003 |
| Tresiba Flextouch U-100Insulin Degludec | 16 | $21,323 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 11 | $20,684 |
| Repatha SureclickEvolocumab | 33 | $19,589 |
| SymbicortBudesonide/Formoterol Fumarate | 38 | $18,926 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $922 | $173,256199 claims |
| Lilly USA, LLCMounjaro, Trulicity | $714 | $130,195109 claims |
| Novo NordiskOzempic | $459 | $129,01284 claims |
| PfizerEliquis, Premarin | $140 | $125,853181 claims |
| Boehringer IngelheimJardiance, Glyxambi | $748 | $72,85689 claims |
| MerckJanuvia | $259 | $40,44948 claims |
| GSKTrelegy Ellipta, Shingrix | $195 | $33,90451 claims |
| Johnson & JohnsonXarelto | $318 | $26,00341 claims |
| Astellas Pharma US IncMyrbetriq | $35 | $8,20229 claims |
| AbbVieSynthroid | $180 | $2,81238 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 7,282 family medicine providers in Florida.
Other family medicine in Blountstown
- Hugh ColemanDaytona Beach$115.5M
- Alexander WhiteDaytona Beach$69.7M
- Ronald SurowitzJupiter$38.3M
- Bruce RankinDeland$36.7M
- Keila HooverMiami$33.7M
- John NardandreaOcala$30.8M
- Jorge CasoMiami$22.6M
- Sharrell CooperPalm Coast$16.9M
- Christopher GallowayMelbourne$15.6M
- Dario AltamiranoHialeah$15.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.